Rabipur Rabies vaccine product alert for health professionals
Reports of rubber particles after reconstitution- recommendations to minimise the risk of particles
On 20 August 2024, Bavarian Nordic in agreement with the Medicines and Healthcare products Regulatory Agency (MHRA) sent a communication out to customers regarding reports of rubber particles after reconstitution of the Rabipur rabies vaccine.
Recommendations have been provided to minimise the risk of particles. Information and advice is also available on the Valneva website for health professionals - see their direct healthcare professional communication letter here.
An analysis has revealed that these particles consisted of rubber, which was transferred from the rubber stopper of the vaccine vials during the reconstitution process (so called "coring").
Reconstituted Rabipur vaccine should be carefully visually inspected and must not be administered in case of visible particles. The letter contains recommendations on how to perform the reconstitution process, with the aim of minimising the risk of particles caused by "coring".
Health professionals with product quality complaints or clinical enquiries about the Rabipur vaccine should contact the manufacturers (see letter for contact details).
Suspected adverse drug reactions can be reported to the MHRA through the Yellow Card scheme and to Valneva.
Explore more
Help us to adapt a Travel Health Resource for UK Travellers
Take part in a study that aims to help UK travellers make informed choices about Japanese encephalitis (JE) vaccination
Updated: 16 July 2026Updated guidelines for malaria prevention in travellers from the UK
UK Health Security Agency have published updated malaria guidelines for 2026
Updated: 14 July 2026Shigella and Salmonella cases reported in travellers returning from Cape Verde
A food and water hygiene reminder
Updated: 07 July 2026Worldwide dengue risk reminder
Dengue is a mosquito-spread virus found in tropical and subtropical world regions, including parts of mainland Europe
Updated: 09 July 2026Mefloquine shortage
Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) continues
Updated: 11 June 2026Help us to adapt a Travel Health Resource for UK Travellers
Take part in a study that aims to help UK travellers make informed choices about Japanese encephalitis (JE) vaccination.
Find out moreGet TravelHealthPro on your site
Integrate features of TravelHealthPro into your own website with our API and widget
